ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,861 | -1,245 | -3,811 | -3,399 | -2,598 |
| Depreciation Amortization | 47 | 24 | 92 | 69 | 45 |
| Other Working Capital | 86 | -251 | -244 | -315 | -172 |
| Other Operating Activity | 182 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-2,546 | $-1,472 | $-3,963 | $-3,646 | $-2,725 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -39 | -35 | -26 |
| Investing Cash Flow | $0 | $0 | $-39 | $-35 | $-26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -3 | N/A | 4,386 | 4,436 | -47 |
| Common Stock Repurchased | N/A | N/A | -3 | N/A | N/A |
| Financing Cash Flow | $-3 | $0 | $4,383 | $4,436 | $-47 |
| Beginning Cash Position | 4,884 | 4,884 | 4,502 | 4,502 | 4,502 |
| End Cash Position | 2,335 | 3,412 | 4,884 | 5,258 | 1,705 |
| Net Cash Flow | $-2,549 | $-1,472 | $381 | $755 | $-2,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,546 | -1,472 | -3,963 | -3,646 | -2,725 |
| Capital Expenditure | N/A | N/A | -39 | -35 | -26 |
| Free Cash Flow | -2,546 | -1,472 | -4,002 | -3,681 | -2,751 |